|
🐜
|
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.
66 auth.
S. Antonarakis,
J. Rossiter,
M. Young,
J. Horst,
P. Moerloose,
S. Sommer,
R. Ketterling,
H. Kazazian,
C. Négrier,
C. Vinciguerra,
J. Gitschier,
M. Goossens,
E. Girodon,
N. Ghanem,
F. Plassa,
...
J. Lavergne,
M. Vidaud,
J. M. Costa,
Y. Laurian,
S. W. Lin,
S. R. Lin,
M. Shen,
D. Lillicrap,
S. Taylor,
S. Windsor,
S. Valleix,
K. Nafa,
Y. Sultan,
M. Delpech,
C. Vnencak-Jones,
J. Phillips,
R. Ljung,
E. Koumbarelis,
A. Gialeraki,
T. Mandalaki,
P. Jenkins,
P. Collins,
K. Pasi,
A. Goodeve,
I. Peake,
F. Preston,
M. Schwartz,
E. Scheibel,
J. Ingerslev,
D. Cooper,
D. Millar,
V. Kakkar,
F. Giannelli,
J. Naylor,
E. Tizzano,
M. Baiget,
M. Doménech,
C. Altisent,
J. Tusell,
M. Beneyto,
J. Lorenzo,
C. Gaucher,
C. Mazurier,
K. Peerlinck,
G. Matthijs,
J. Cassiman,
J. Vermylen,
P. Mori,
M. Acquila,
D. Caprino,
H. Inaba
|
8 |
1995 |
8
🐜
|
|
🐢
|
Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance
Virginie Terraube,
J. O’Donnell,
P. Jenkins
|
7 |
2010 |
7
🐢
|
|
🐜
|
Identification and Three-dimensional Structural Analysis of Nine Novel Mutations in Patients with Prothrombin Deficiency
8 auth.
S. Akhavan,
P. Mannucci,
M. Lak,
G. Mancuso,
M. Mazzucconi,
A. Rocino,
...
P. Jenkins,
S. Perkins
|
6 |
2000 |
6
🐜
|
|
🦁
|
Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease.
P. Jenkins,
K. Pasi,
S. Perkins
|
6 |
1998 |
6
🦁
|
|
🐢
|
Identification of Type 2 von Willebrand Disease in Previously Diagnosed Type 1 Patients: a Reappraisal Using Phenotypes, Genotypes and Molecular Modelling
8 auth.
I. Nitu‐Whalley,
A. Riddell,
C. Lee,
K. Pasi,
D. Owens,
M. Enayat,
...
S. Perkins,
P. Jenkins
|
5 |
2000 |
5
🐢
|
|
🦁
|
Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex.
P. Jenkins,
Jan Freas,
Kyla M Schmidt,
Qian Zhou,
P. Fay
|
5 |
2002 |
5
🦁
|
|
🐬
|
Use of the collagen‐binding assay for von Willebrand factor
in the analysis of type 2M von Willebrand disease:
a comparison with the ristocetin cofactor assay
A. Riddell,
P. Jenkins,
I. Nitu‐Whalley,
A. Mccraw,
Christine A. Lee,
S. Brown
|
5 |
2002 |
5
🐬
|
|
🐜
|
Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors’ Organisation guideline
9 auth.
E. Gray,
S. Kitchen,
A. Bowyer,
P. Chowdary,
P. Jenkins,
P. Murphy,
...
S. Platton,
A. Riddell,
W. Lester
|
5 |
2019 |
5
🐜
|
|
🐜
|
Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease.
8 auth.
M. Enayat,
A. Guilliatt,
G. Surdhar,
P. Jenkins,
K. Pasi,
C. Toh,
...
Michael D. Williams,
F. Hill
|
5 |
2001 |
5
🐜
|
